Latest News
DCP Capital, a $5.5bn private equity firm focused on the consumer, healthcare, education and tech sectors in Asia has acquired Alibaba Group Holdings’s majority stake in Chinese hypermarket chain Sun Art Retail for HKD12.298bn ($1.58bn), according to a report by Reuters.
Japan’s Pension Fund Association for Local Government Officials (Chikyoren) has selected four firms – two from the US and two from Japan – for a global private equity mandate, according to a report by Asia Asset Management.
US-based law firm Honigman is growing its Chicago office with the addition of Richard “Richie” Catalano as a Partner in the Transactions & Counselling Practice Group and Corporate Department.
Pan-European stock exchange operator Euronext NV is optimistic about the outlook for initial public offerings (IPOs) in 2025, driven by private equity funds turning to equity markets to exit their investments, according to a report by Bloomberg.
Healthcare company NeueHealth has signed a definitive merger agreement to be acquired by an affiliate of New Enterprise Associates (NEA) for approximately $1.3bn, according to a report by Pulse 2.0.
Brookfield Asset Management, together with its co-investors, has taken a major step toward completing a €6.1bn ($6.4bn) acquisition of Neoen SA, having secured around 53% of the company’s shares, according to a report by Bloomberg.
Private equity firms and pension funds are pouring unprecedented amounts of money into the UK rental housing market, driven by soaring demand and a persistent housing affordability crisis, according to a report by the Financial Times.
Craigs Investment Partners, a New Zealand wealth management firm, has reached a conditional agreement with global private equity firm TA Associates for a strategic investment.
Saudi Venture Capital (SVC) has committed over SR1.5bn ($400m) to the Jadwa GCC Private Equity Fund 1, which will invest in a diversified, cross-sectorial set of high-potential private equity opportunities across Saudi Arabia and the GCC.
China’s WuXi AppTec subsidiaries have entered into an agreement with US-based private equity firm Altaris to sell its cell and gene therapy manufacturing unit, WuXi Advanced Therapies, for an undisclosed amount, according to a report by Reuters.
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
